Chris@CNW, Author at CannabisNewsWire

WednesdayMay 15, 2024 10:00 am

Officials Highlight Areas of Failure as Cannabis Program in New York Is Overhauled

Major changes are being made at the Office of Cannabis Management (OCM) in New York State after the governor directed that a review be conducted. The review, as ordered by Governor Kathy Hochul, led to the discovery that New York’s rollout of legalized recreational cannabis had been a failure. One report, released last week, cites an underspent budget and inexperienced leadership as some of the errors by the office. According to the report, a total of $26 million, which could have assisted in clearing application backlogs, remained unused. In her statement, Hochul announced that the director of the OCM, Chris…

WednesdayMay 15, 2024 9:45 am

More Than Just Green: Zoned Properties Inc. (ZDPY) Experts in Complexities of Opening a Cannabis Dispensary

With cannabis legalization exploding nationwide, there are now over 19,500 incorporated U.S. cities, town, and villages that will govern local cannabis regulations Zoned Properties is comprised of a team of experts in cannabis zoning codes utilizing proprietary technology to identify premium cannabis dispensary locations Focused on its dispensary landlord model, the company has listed its largest cultivation property in Arizona for sale for $16 million The cannabis industry is flourishing, but opening a dispensary isn't a walk in the park. Aspiring entrepreneurs face a maze of regulations and considerations beyond simply having a quality supply chain. Unprecedented Geographic Growth California…

TuesdayMay 14, 2024 4:20 pm

420 with CNW — Germany May Initiate Legal Adult-Use Cannabis Sales Via Regulations, Bypassing Standalone Law

Germany is progressing with the next stage of cannabis legalization by initiating a pilot program for commercial sales using an administrative process instead of waiting for legislators to pass a separate measure as initially anticipated. It has long been expected that lawmakers would introduce and approve additional sales bills to complete the second phase of legalization. However, the government is opting for a rulemaking approach, potentially expediting the implementation process. Cannabis legalization was set in motion under a measure led by Germany’s Ministry of Health, which went into force in April 2024. This allows adults to use and grow marijuana…

TuesdayMay 14, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation

Lexaria, a global innovator in drug delivery platforms, just announced its newest relationship with the National Research Council of Canada (“NRC”) Specific molecular characteristics of the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, processed with Lexaria’s patented DehydraTECH(TM) technology, will be evaluated Previous research has shown that using a DehydraTECH-semaglutide capsule composition yields a 43% higher peak level of semaglutide in blood compared to Rybelsus(R). This has potential for increased weight-loss and diabetic control Lexaria’s management is confident that this partnership will complement the company’s animal and human pharmacokinetic and pharmacodynamic studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a…

MondayMay 13, 2024 4:20 pm

420 with CNW — Marijuana Advocates See Rescheduling as Tool to Enact Reforms in Prohibitionist States

The anticipated reclassification of cannabis by the federal government to a less-dangerous category may not have an immediate effect on states where cannabis use for either recreational or medical purposes is still illegal. Nonetheless, cannabis legalization proponents see the federal shift as potentially influencing state policymakers who have been hesitant about endorsing cannabis. Matthew Schweich, head of the Marijuana Policy Project, a prolegalization advocacy group, often encounters state legislators who express potential support but are reluctant due to federal illegality. While reclassification wouldn’t legalize cannabis outright, Schweich believes it could alleviate some concerns among state legislators, potentially making them more…

MondayMay 13, 2024 12:45 pm

Illinois Cannabis Convention & Expo to Attract the Biggest Traders in the Cannabis Spectrum

The NECANN Illinois Cannabis Convention 7 Expo is being held May 31 – June 1, 2024, at the Schaumburg Convention Center, Chicago, IL. One of the biggest cannabis B2B conventions in the country, the event will witness prominent growers, traders, enthusiasts, patients, educators, dealers, and top industry leaders. Newcomers as well as seasoned businesses can showcase their products or unique ideas at the exhibitor booths to gain visibility among the top investors, industries, and traders in the cannabis industry. The exhibitor booths significantly attract the crowds as they have fresh and innovative items on display. Operating since 2014, NECANN events…

MondayMay 13, 2024 10:00 am

Canadian Medical Marijuana Exports Rise Amid Falling Local Sales

According to statistics from Health Canada, the regulator of the marijuana industry in Canada, exports of medical marijuana from the country have reached a record-setting $189 million as local producers grapple with numerous domestic challenges ranging from prohibitive taxes to cutthroat competition on the domestic market. The current value of exports for the year ended March 2024 marked a 36% increase from exports registered last year ($116.5 million). This notable increase in exports follows a growing trend that saw the country export medical marijuana products worth $5.8 million in the 2019–2020 fiscal year, $28.4 million in 2020–2021 fiscal year and…

FridayMay 10, 2024 4:20 pm

420 with CNW — Reports Confirm DEA Is Close to Reclassifying Marijuana

The U.S. Drug Enforcement Administration (DEA) is set to change the classification of cannabis. The proposal, pending review by the White House Office of Management and Budget (OMB), acknowledges marijuana’s medical potential and implies that it is less prone to abuse compared to other certain drugs. However, it does not advocate for the complete legalization of marijuana for recreational purposes. The move, disclosed by anonymous sources familiar with the matter, signals a major policy change for the DEA and a shift in U.S. drug policy. Once approved, the agency will invite public feedback on moving cannabis from Schedule I to…

FridayMay 10, 2024 10:00 am

Defense Lawyers Group Urges Biden to Release Prisoners Serving Marijuana Sentences

NACDL, the National Association of Criminal Defense Lawyers, has written a letter to the White House urging President Joseph Biden and his administration to decriminalize cannabis and also commute all sentences of individuals in prison over federal cannabis convictions. In their letter, the association says it is advocating for compassionate release, second chances and the immediate commuting of sentences of those having convictions for nonviolent cannabis offenses. The letter written by NACDL was sent on the same day last week when the U.S. Drug Enforcement Administration (DEA) is reported to have made a decision to reclassify marijuana to Schedule III…

ThursdayMay 09, 2024 4:20 pm

420 with CNW — Study Finds Frequent Cannabis Use Doesn’t Cause Paranoia, Lower Motivation

Recent research on the effects of regular marijuana usage disproves popular perceptions about the drug by showing no connection between habitual users’ decreased motivation or paranoia. The study found no indication of a marijuana-induced hangover the following day. One of the unexpected results was that long-term users did not exhibit a decline in desire or effort-exertion willingness, either due to internal or external factors. In fact, consumers who used the product more frequently claimed to be more motivated and to have experienced more negative emotions and impulsivity. The study highlights both expected and unexpected results, challenging misconceptions surrounding cannabis’ effects.…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Author: Chris@CNW